Our focus is patients, 
Our passion is innovation®

MannKind Corporation develops patient-focused drug therapies and innovative technology solutions.

More

Advanced Science 
Practical Design

We specialize in innovative technologies with proven ease-of-use and patient acceptance.

More

Patient-Friendly
Inhalation Treatments

Needle-free, self-administered Inhalation Treatment Systems for both chronic and acute diseases.

More

In Partnership
Your Drug, Our Delivery.

Our Technosphere® technology can accommodate a wide variety of APIs required by specific drug therapies.

More

About Us

MannKind Corporation (NASDAQ and TASE: MNKD) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes.  More

 

facebook-c_130x50      twitter_130x50

 

MannKind Corporation’s 2017
Annual Meeting of Stockholders
was held on May 18, 2017.
Click here to view an inspiring
panel discussion
from
the meeting.
alfreeza

FDA Approved

For information about AFREZZA®,
please visit www.AFREZZA.com.